| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-09-04 Tx date 2018-08-31 |
$KBB
Kaneh Bosm BioTechnology Inc. |
beukman, eugene
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-112,000
-200,000 vol $0.56 each |
0 | |
| Filed 2018-06-27 Tx date 2018-06-26 |
$KBB
Kaneh Bosm BioTechnology Inc. |
Ausburn, Kent E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,000
+100,000 vol $0.51 each |
350,000 | |
| Filed 2018-06-27 Tx date 2018-06-26 |
$KBB
Kaneh Bosm BioTechnology Inc. |
de jonge, rudy
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$357,000
+700,000 vol $0.51 each |
1,100,000 | |
| Filed 2018-05-01 Tx date 2018-04-27 |
$KBB
Kaneh Bosm BioTechnology Inc. |
beukman, eugene
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-05-01 Tx date 2018-04-27 |
$KBB
Kaneh Bosm BioTechnology Inc. |
beukman, eugene
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2018-05-01 Tx date 2018-04-27 |
$KBB
Kaneh Bosm BioTechnology Inc. |
beukman, eugene
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2018-05-01 Tx date 2018-04-27 |
$KBB
Kaneh Bosm BioTechnology Inc. |
beukman, eugene
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-01 Tx date 2016-06-29 |
$KBB
Kaneh Bosm BioTechnology Inc. |
Ausburn, Kent E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+200,000 vol $0.20 each |
300,000 | |
| Filed 2018-03-01 Tx date 2017-11-02 |
$KBB
Kaneh Bosm BioTechnology Inc. |
Ausburn, Kent E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$7,000
+100,000 vol $0.07 each |
126,000 | |
| Filed 2018-03-01 Tx date 2017-11-02 |
$KBB
Kaneh Bosm BioTechnology Inc. |
Ausburn, Kent E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,250
+100,000 vol $0.0525 each |
152,205 | |
| Filed 2018-03-01 Tx date 2018-02-28 |
$KBB
Kaneh Bosm BioTechnology Inc. |
Ausburn, Kent E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-26,000 vol |
100,000 | |
| Filed 2018-03-01 Tx date 2017-10-05 |
$KBB
Kaneh Bosm BioTechnology Inc. |
Ausburn, Kent E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,600
-40,000 vol $0.09 each |
52,205 | |
| Filed 2018-02-26 Tx date 2018-02-22 |
$KBB
Kaneh Bosm BioTechnology Inc. |
de jonge, rudy
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,500
-30,000 vol $0.25 each |
2,261,901 | |
| Filed 2018-01-15 Tx date 2018-01-12 |
$KBB
Kaneh Bosm BioTechnology Inc. |
de jonge, rudy
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,940
-13,500 vol $0.44 each |
2,291,901 | |
| Filed 2018-01-15 Tx date 2018-01-11 |
$KBB
Kaneh Bosm BioTechnology Inc. |
de jonge, rudy
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,740
-8,500 vol $0.44 each |
2,305,401 | |
| Filed 2018-01-15 Tx date 2018-01-09 |
$KBB
Kaneh Bosm BioTechnology Inc. |
de jonge, rudy
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,900
-10,000 vol $0.39 each |
2,334,401 | |
| Filed 2018-01-15 Tx date 2018-01-08 |
$KBB
Kaneh Bosm BioTechnology Inc. |
de jonge, rudy
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,312.50
-12,500 vol $0.425 each |
2,361,901 | |
| Filed 2018-01-15 Tx date 2018-01-08 |
$KBB
Kaneh Bosm BioTechnology Inc. |
de jonge, rudy
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,350
-17,500 vol $0.42 each |
2,344,401 | |
| Filed 2018-01-15 Tx date 2018-01-10 |
$KBB
Kaneh Bosm BioTechnology Inc. |
de jonge, rudy
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,800
-20,000 vol $0.44 each |
2,314,401 | |
| Filed 2018-01-15 Tx date 2018-01-10 |
$KBB
Kaneh Bosm BioTechnology Inc. |
de jonge, rudy
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-235.00
-500 vol $0.47 each |
2,313,901 |